Zyvi IV 500 contains damoctocog alfa pegol, a recombinant DNA-derived, PEGylated Factor VIII concentrate. This injectable is used for treating hemophilia A in adults and adolescents aged 12 years and older. Manufactured by Bayer Pharmaceutical, this product (YJ code: 6343453D1020) is available as a 500 IU bottle with dissolving solution.
Zyvi IV 500
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →